FDA Letter API

Texas Plum Line

Letter data

Company
Texas Plum Line
Recipient
Texas Plum Line | United States
Issue date
2018-05-03
Posted date
Not available
FDA office
United States
Subject
Not available
Product
Not available
CMS ID
534263
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Texas Plum Line MARCS-CMS 534263 — May 03, 2018 More Warning Letters Warning Letters About Warning and Close-Out Letters Recipient: Texas Plum Line United States Issuing Office: United States Office of Human and Animal Food Operations West Division 3 4040 North Central Expressway, Suite 300 Dallas, Texas 75204 May 3, 2018 UPS OVERNIGHT Connie J. Bingham, Owner Texas Plum Line 5060 Helium Road Amarillo, Texas 79124 Dear Ms. Bingham The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter 2017-DAL-WL-29 dated September 22, 2017. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. If you choose to reestablish or sale your operations, the Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Jessica E. Hensley Director of Compliance Branch, OHAF-W3 Content current as of: 05/07/2018